CN113136395A - Expression vector of membrane protein YcbM and expression and purification method thereof - Google Patents
Expression vector of membrane protein YcbM and expression and purification method thereof Download PDFInfo
- Publication number
- CN113136395A CN113136395A CN202010049434.6A CN202010049434A CN113136395A CN 113136395 A CN113136395 A CN 113136395A CN 202010049434 A CN202010049434 A CN 202010049434A CN 113136395 A CN113136395 A CN 113136395A
- Authority
- CN
- China
- Prior art keywords
- ycbm
- expression
- membrane protein
- expression vector
- escherichia coli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses an expression vector of membrane protein YcbM and an expression and purification method thereof. The nucleotide sequence of the expression vector is shown as SEQ ID NO.2, and the expression vector comprises: the bacteriophage T7 promoter; an Escherichia coli ribosome binding site which comprises an NcoI sequence CCATGG, an Escherichia coli membrane protein YcbM sequence shown in SEQ ID NO.1 and a BamHI site GGATCC; a tobacco etch virus cysteine protease cleavage site GAGAACCTGTACTTCCAATCC; NdeI restriction site CATATG; a hyper-folding Venus fluorescent protein coding sequence; XhoI cleavage site CTCGAG; 6 histidine sites and the stop codon TAG. The invention uses the fluorescent protein with rigid molecules as a screening marker and an expression process indicator, and the fluorescent protein can be folded rapidly due to the rigid structure at the molecular level, and can help the nitrogen-terminal membrane protein YcbM to stabilize the conformation. The expression vector constructed by the invention can realize the mass expression of the membrane protein YcbM and can be used for the high-throughput screening of the subsequent novel antibiotics.
Description
Technical Field
The invention belongs to the technical field of protein production, and relates to an expression vector of an aliphatic sulfonate transporter (YcbM) and an expression and purification method thereof.
Background
The cell membrane is the boundary between the inside and the outside of the cell, is an important organelle, and plays important roles in information transfer, energy transmission and material exchange. The target of the drug action is often located on the cell membrane. It is currently known that more than 50% of the targets for drug action are membrane proteins. Therefore, the method has very important significance for the research of the membrane protein.
However, since the membrane protein has a few natural states and a multi-transmembrane structure, the membrane protein is easy to be folded mistakenly and has a complex structure, and thus, the large-scale preparation of the membrane protein is always a difficult point and a hot point. In China, no biological company can express transmembrane proteins for more than 12 times, and only one or two companies can express transmembrane proteins for four times.
Coli has been the first choice for protein expression as a commonly used expression host, however, even the proteins of e.coli themselves are difficult to express in large amounts in e.coli. Currently, abuse of antibiotics causes a dilemma that the antibiotics cannot resist drug-resistant bacteria within 50 years. Therefore, a great amount of expression membrane protein is used as an action target of the antibiotic, and a pilot technical support is provided for the high-throughput screening of the subsequent non-denaturing mass spectrum.
Disclosure of Invention
The invention aims to provide an expression vector for expressing a large amount of membrane protein YcbM and an expression and purification method thereof. The invention establishes a high-efficiency fusion expression system aiming at the escherichia coli membrane protein YcbM, and can be used for the subsequent further research on the non-denatured real-time monitoring mass spectrum of the protein.
The technical scheme for realizing the purpose of the invention is as follows:
the expression vector of the membrane protein YcbM takes the hyper-folding Venus fluorescent protein (Chinese patent application 201910347575.3) which is obtained in the laboratory and used for positioning the Chlamydomonas reinhardtii protein as an initial protein skeleton, and obtains a fluorescent protein expression label with rigid molecules by further optimizing the composition of codons used for sequence expression, and is suitable for large-scale expression of the Escherichia coli membrane protein. The invention utilizes the fluorescent protein with rigid molecules as a screening marker and an expression process indicator, and the fluorescent protein can be folded rapidly due to the rigid structure at the molecular level and helps the nitrogen-terminal membrane protein YcbM to stabilize the conformation.
The expression vector of the membrane protein YcbM is expression plasmid pLy077-YcbM (SEQ ID NO.2), and comprises: the bacteriophage T7 promoter; an Escherichia coli ribosome binding site comprising an NcoI sequence CCATGG, an Escherichia coli membrane protein YcbM sequence (SEQ ID NO.1) and a BamHI site GGATCC; a tobacco etch virus cysteine protease cleavage site GAGAACCTGTACTTCCAATCC; NdeI restriction site CATATG; a hyper-folding Venus fluorescent protein coding sequence; XhoI cleavage site CTCGAG; 6 histidine sites and the stop codon TAG.
The invention also provides an expression and purification method of the expression vector of the membrane protein YcbM, which comprises the following specific steps:
and 2, inoculating the selected mutant strain transformant into a culture medium for amplification culture, and carrying out large-scale induction expression on the membrane protein YcbM by using 1mM IPTG.
Preferably, in step 1, the Escherichia coli is Escherichia coli DH5 alpha or Escherichia coli BL21(DE 3).
Preferably, in step 2, the culture medium is an LB culture medium or a TB culture medium.
The invention introduces the target gene and the codon optimized hyper-folding Venus fluorescent protein with molecular rigidity into the expression vector by fully synthesizing the expression vector, and greatly improves the transcription and translation efficiency of the target gene by optimizing the primary sequence of the nucleic acid coding. In addition, the folding speed of the carboxyl-terminal rigid fluorescent protein is controlled, so that the target membrane protein is helped to be correctly folded and inserted into the membrane. The rigid fluorescent protein can be used for monitoring the real-time expression process of the protein and protecting the carboxyl terminal of the protein, so that the target protein is enriched. The invention realizes high-flux screening of novel antibiotics through mass expression and later purification of escherichia coli membrane protein, and has important commercial prospect.
Drawings
FIG. 1 is a diagram showing the result of PCR agarose gel electrophoresis of the coding sequence of the YcbM protein.
FIG. 2 is a schematic diagram of the structure of the pLy077-YcbM plasmid.
FIG. 3 is a diagram showing the results of PCR verification of pLy077-YcbM colonies.
FIG. 4 shows the results of single-restriction double-restriction agarose gel electrophoresis of NcoI and BamHI of plasmid pLy 077-YcbM.
FIG. 5 is a fluorescence image of colonies on transformed agar plates.
FIG. 6 is fluorescence imaging after induction in TB medium and comparison of total mycoprotein before and after induction, using Escherichia coli BL21 as expression strain.
Detailed Description
The invention will be further described with reference to specific embodiments and figures, but is not limited thereto. The procedures, conditions, reagents, experimental methods and the like for carrying out the present invention are general knowledge and common general knowledge in the art except for the contents specifically mentioned below, and the present invention is not particularly limited.
The materials used in the examples are as follows:
1. cell source
Coli strains DH5 α, BL21(DE3), C41(DE3), C43(DE3) were purchased from Wuhanling vast Bio Inc.
2. Source of plasmids
The pLy077 plasmid and the YcbM coding sequence were synthesized by Shanghai Biotechnology, Inc., the pLy077 plasmid contains: the bacteriophage T7 promoter; coli ribosome binding site comprising the NcoI sequence CCATGG and BamHI site GGATCC; a tobacco etch virus cysteine protease cleavage site GAGAACCTGTACTTCCAATCC; NdeI restriction site CATATG; a hyper-folding Venus fluorescent protein coding sequence; XhoI cleavage site CTCGAG; 6 histidine sites and the stop codon TAG. pLy077 the plasmid 077 and the coding sequence of YcbM are shown in the sequence listing.
3. Source of primers
The synthetic primers were all from Biotechnology, Inc. of Ongbenaceae, Beijing.
4. Primary reagent
Tryptone, yeast extract, NaCl, Tris-baes were purchased from Sigma; restriction endonucleases, phusion enzymes, were purchased from Thermo Fisher; rTaq enzyme, T4 ligase, was purchased from Takara. The plasmid miniprep kit and the gel recovery kit were purchased from Axygen corporation. NTP, DEPC water and RNase inhibitor were purchased from Shanghai Biotechnology Ltd.
EXAMPLE 1 cloning of the YcbM Gene
Cloning of YcbM
a) A completely new YcbM coding sequence (SEQ ID NO.1) was designed and synthesized based on comparison of codons used in the YcbM sequence with the frequency of usage of Escherichia coli codons in the Kazusa online database (http:// www.kazusa.or.jp/codon /). And then amplified by a PCR method. The PCR reaction system configuration is shown in Table 1.
TABLE 1 PCR reaction System preparation Table
The PCR results are shown in FIG. 1. The length of the target fragment is 810bp, and the optimal annealing temperature is 52 ℃.
b) Recovering target DNA, cutting the target fragment and pLy077 vector by using Nco I and BamHI enzyme, then carrying out agarose gel electrophoresis, and recovering the cut enzyme product; the recovered target fragment and pLy077 vector fragment were added to a small centrifuge tube at a molar ratio of 5:1, T4 ligase was added, and ligation was performed overnight at 16 ℃.
c) mu.L of the above ligation product was transformed into 80. mu.L of DH 5. alpha. competent cells by heat shock at 42 ℃ and 700. mu.L of LB medium was added thereto, followed by shaking at 37 ℃ and culturing at 200 rpm for 45 minutes.
d) Centrifuging the bacterial liquid at the rotating speed of 4000 rpm for 1 minute, and sucking 700 mu L of supernatant; after the remaining medium was gently aspirated by a pipette, the medium was spread on an LB solid plate containing ampicillin, and the plate was placed upside down in an incubator at 37 ℃ and cultured for 12 hours.
e) And (3) selecting a single colony in the plate, carrying out small-amount amplification, extracting plasmids, carrying out single enzyme digestion and double enzyme digestion on the extracted plasmids by using Nco I and BamHI, carrying out agarose gel electrophoresis identification, and carrying out sequencing identification to obtain the expression vector pLy077-YcbM of the membrane protein YcbM, wherein the structural schematic diagram of the plasmids is shown in FIG. 2. FIG. 3 is a diagram showing the results of PCR verification of pLy077-YcbM colonies. FIG. 4 shows the results of single-restriction double-restriction agarose gel electrophoresis of NcoI and BamHI of plasmid pLy 077-YcbM.
Example 2 expression of YcbM
Inducible expression of fusion protein YcbM-superfolder fluorescent protein
Transferring the correctly identified pLy077-YcbM plasmid into Escherichia coli expression hosts BL21(DE3) and DH5 alpha, and coating the plasmids with 0.1mM isopropyl thiogalactoside (IPTG) to obtain stably transformed colonies; by detecting the fluorescence of the colonies, fig. 5 is a fluorescence map of the colonies on the transformed agar plate, and it can be seen from the presence or absence of fluorescence that whether the colonies contain the recombinant plasmid or not, and the colonies containing the recombinant plasmid show fluorescence, and it can be seen that a mutant strain expressing a large amount of the target protein is obtained.
Each colony was inoculated into LB and TB liquid media containing 100. mu.g/ml ampicillin, and cultured overnight at 37 ℃ at 200 rpm to give overnight-cultured bacteria. The overnight bacteria were inoculated into 750mL LB and TB medium at a ratio of 1:250 and cultured at 30 ℃ to OD at 230 rpm600Reaching 0.8-1.0, adding IPTG with final concentration of 0.5mM, and culturing at 25 deg.C for 2-6 hr. The cells were collected by centrifugation at 4000 rpm for 15 minutes. And (3) suspending the thalli in a PBS buffer solution, and centrifuging for 15 minutes at 4000 rpm to obtain the thalli containing the YcbM fusion expression protein. FIG. 6 shows fluorescence induced in TB medium by E.coli BL21 as expression strainFrom the photo-imaging and comparison graphs of whole bacterial proteins before and after induction, as can be seen from FIG. 6, the expression level of YcbM protein is the highest after the induction of Escherichia coli BL21 in TB culture medium for 4 h.
Sequence listing
<110> Nanjing university of science and technology
<120> expression vector of membrane protein YcbM and expression purification method thereof
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 789
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
atggcgaccc cggtgaaaaa atggctgctg cgcgtggcgc cgtggtttct gccggtgggc 60
attgtggcgg tgtggcagct ggcgagcagc gtgggctggc tgagcacccg cattctgccg 120
agcccggaag gcgtggtgac cgcgttttgg accctgagcg cgagcggcga actgtggcag 180
catctggcga ttagcagctg gcgcgcgctg attggcttta gcattggcgg cagcctgggc 240
ctgattctgg gcctgattag cggcctgagc cgctggggcg aacgcctgct ggataccagc 300
attcagatgc tgcgcaacgt gccgcatctg gcgctgattc cgctggtgat tctgtggttt 360
ggcattgatg aaagcgcgaa aatttttctg gtggcgctgg gcaccctgtt tccgatttat 420
attaacacct ggcatggcat tcgcaacatt gatcgcggcc tggtggaaat ggcgcgcagc 480
tatggcctga gcggcattcc gctgtttatt catgtgattc tgccgggcgc gctgccgagc 540
attatggtgg gcgtgcgctt tgcgctgggc ctgatgtggc tgaccctgat tgtggcggaa 600
accattagcg cgaacagcgg cattggctat ctggcgatga acgcgcgcga atttctgcag 660
accgatgtgg tggtggtggc gattattctg tatgcgctgc tgggcaaact ggcggatgtg 720
agcgcgcagc tgctggaacg cctgtggctg cgctggaacc cggcgtatca tctgaaagaa 780
gcgaccgtg 789
<210> 2
<211> 6784
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
tggcgaatgg gacgcgccct gtagcggcgc attaagcgcg gcgggtgtgg tggttacgcg 60
cagcgtgacc gctacacttg ccagcgccct agcgcccgct cctttcgctt tcttcccttc 120
ctttctcgcc acgttcgccg gctttccccg tcaagctcta aatcgggggc tccctttagg 180
gttccgattt agtgctttac ggcacctcga ccccaaaaaa cttgattagg gtgatggttc 240
acgtagtggg ccatcgccct gatagacggt ttttcgccct ttgacgttgg agtccacgtt 300
ctttaatagt ggactcttgt tccaaactgg aacaacactc aaccctatct cggtctattc 360
ttttgattta taagggattt tgccgatttc ggcctattgg ttaaaaaatg agctgattta 420
acaaaaattt aacgcgaatt ttaacaaaat attaacgttt acaatttcag gtggcacttt 480
tcggggaaat gtgcgcggaa cccctatttg tttatttttc taaatacatt caaatatgta 540
tccgctcatg aattaattct tagaaaaact catcgagcat caaatgaaac tgcaatttat 600
tcatatcagg attatcaata ccatattttt gaaaaagccg tttctgtaat gaaggagaaa 660
actcaccgag gcagttccat aggatggcaa gatcctggta tcggtctgcg attccgactc 720
gtccaacatc aatacaacct attaatttcc cctcgtcaaa aataaggtta tcaagtgaga 780
aatcaccatg agtgacgact gaatccggtg agaatggcaa aagtttatgc atttctttcc 840
agacttgttc aacaggccag ccattacgct cgtcatcaaa atcactcgca tcaaccaaac 900
cgttattcat tcgtgattgc gcctgagcga gacgaaatac gcgatcgctg ttaaaaggac 960
aattacaaac aggaatcgaa tgcaaccggc gcaggaacac tgccagcgca tcaacaatat 1020
tttcacctga atcaggatat tcttctaata cctggaatgc tgttttcccg gggatcgcag 1080
tggtgagtaa ccatgcatca tcaggagtac ggataaaatg cttgatggtc ggaagaggca 1140
taaattccgt cagccagttt agtctgacca tctcatctgt aacatcattg gcaacgctac 1200
ctttgccatg tttcagaaac aactctggcg catcgggctt cccatacaat cgatagattg 1260
tcgcacctga ttgcccgaca ttatcgcgag cccatttata cccatataaa tcagcatcca 1320
tgttggaatt taatcgcggc ctagagcaag acgtttcccg ttgaatatgg ctcataacac 1380
cccttgtatt actgtttatg taagcagaca gttttattgt tcatgaccaa aatcccttaa 1440
cgtgagtttt cgttccactg agcgtcagac cccgtagaaa agatcaaagg atcttcttga 1500
gatccttttt ttctgcgcgt aatctgctgc ttgcaaacaa aaaaaccacc gctaccagcg 1560
gtggtttgtt tgccggatca agagctacca actctttttc cgaaggtaac tggcttcagc 1620
agagcgcaga taccaaatac tgtccttcta gtgtagccgt agttaggcca ccacttcaag 1680
aactctgtag caccgcctac atacctcgct ctgctaatcc tgttaccagt ggctgctgcc 1740
agtggcgata agtcgtgtct taccgggttg gactcaagac gatagttacc ggataaggcg 1800
cagcggtcgg gctgaacggg gggttcgtgc acacagccca gcttggagcg aacgacctac 1860
accgaactga gatacctaca gcgtgagcta tgagaaagcg ccacgcttcc cgaagggaga 1920
aaggcggaca ggtatccggt aagcggcagg gtcggaacag gagagcgcac gagggagctt 1980
ccagggggaa acgcctggta tctttatagt cctgtcgggt ttcgccacct ctgacttgag 2040
cgtcgatttt tgtgatgctc gtcagggggg cggagcctat ggaaaaacgc cagcaacgcg 2100
gcctttttac ggttcctggc cttttgctgg ccttttgctc acatgttctt tcctgcgtta 2160
tcccctgatt ctgtggataa ccgtattacc gcctttgagt gagctgatac cgctcgccgc 2220
agccgaacga ccgagcgcag cgagtcagtg agcgaggaag cggaagagcg cctgatgcgg 2280
tattttctcc ttacgcatct gtgcggtatt tcacaccgca tatatggtgc actctcagta 2340
caatctgctc tgatgccgca tagttaagcc agtatacact ccgctatcgc tacgtgactg 2400
ggtcatggct gcgccccgac acccgccaac acccgctgac gcgccctgac gggcttgtct 2460
gctcccggca tccgcttaca gacaagctgt gaccgtctcc gggagctgca tgtgtcagag 2520
gttttcaccg tcatcaccga aacgcgcgag gcagctgcgg taaagctcat cagcgtggtc 2580
gtgaagcgat tcacagatgt ctgcctgttc atccgcgtcc agctcgttga gtttctccag 2640
aagcgttaat gtctggcttc tgataaagcg ggccatgtta agggcggttt tttcctgttt 2700
ggtcactgat gcctccgtgt aagggggatt tctgttcatg ggggtaatga taccgatgaa 2760
acgagagagg atgctcacga tacgggttac tgatgatgaa catgcccggt tactggaacg 2820
ttgtgagggt aaacaactgg cggtatggat gcggcgggac cagagaaaaa tcactcaggg 2880
tcaatgccag cgcttcgtta atacagatgt aggtgttcca cagggtagcc agcagcatcc 2940
tgcgatgcag atccggaaca taatggtgca gggcgctgac ttccgcgttt ccagacttta 3000
cgaaacacgg aaaccgaaga ccattcatgt tgttgctcag gtcgcagacg ttttgcagca 3060
gcagtcgctt cacgttcgct cgcgtatcgg tgattcattc tgctaaccag taaggcaacc 3120
ccgccagcct agccgggtcc tcaacgacag gagcacgatc atgcgcaccc gtggggccgc 3180
catgccggcg ataatggcct gcttctcgcc gaaacgtttg gtggcgggac cagtgacgaa 3240
ggcttgagcg agggcgtgca agattccgaa taccgcaagc gacaggccga tcatcgtcgc 3300
gctccagcga aagcggtcct cgccgaaaat gacccagagc gctgccggca cctgtcctac 3360
gagttgcatg ataaagaaga cagtcataag tgcggcgacg atagtcatgc cccgcgccca 3420
ccggaaggag ctgactgggt tgaaggctct caagggcatc ggtcgagatc ccggtgccta 3480
atgagtgagc taacttacat taattgcgtt gcgctcactg cccgctttcc agtcgggaaa 3540
cctgtcgtgc cagctgcatt aatgaatcgg ccaacgcgcg gggagaggcg gtttgcgtat 3600
tgggcgccag ggtggttttt cttttcacca gtgagacggg caacagctga ttgcccttca 3660
ccgcctggcc ctgagagagt tgcagcaagc ggtccacgct ggtttgcccc agcaggcgaa 3720
aatcctgttt gatggtggtt aacggcggga tataacatga gctgtcttcg gtatcgtcgt 3780
atcccactac cgagatatcc gcaccaacgc gcagcccgga ctcggtaatg gcgcgcattg 3840
cgcccagcgc catctgatcg ttggcaacca gcatcgcagt gggaacgatg ccctcattca 3900
gcatttgcat ggtttgttga aaaccggaca tggcactcca gtcgccttcc cgttccgcta 3960
tcggctgaat ttgattgcga gtgagatatt tatgccagcc agccagacgc agacgcgccg 4020
agacagaact taatgggccc gctaacagcg cgatttgctg gtgacccaat gcgaccagat 4080
gctccacgcc cagtcgcgta ccgtcttcat gggagaaaat aatactgttg atgggtgtct 4140
ggtcagagac atcaagaaat aacgccggaa cattagtgca ggcagcttcc acagcaatgg 4200
catcctggtc atccagcgga tagttaatga tcagcccact gacgcgttgc gcgagaagat 4260
tgtgcaccgc cgctttacag gcttcgacgc cgcttcgttc taccatcgac accaccacgc 4320
tggcacccag ttgatcggcg cgagatttaa tcgccgcgac aatttgcgac ggcgcgtgca 4380
gggccagact ggaggtggca acgccaatca gcaacgactg tttgcccgcc agttgttgtg 4440
ccacgcggtt gggaatgtaa ttcagctccg ccatcgccgc ttccactttt tcccgcgttt 4500
tcgcagaaac gtggctggcc tggttcacca cgcgggaaac ggtctgataa gagacaccgg 4560
catactctgc gacatcgtat aacgttactg gtttcacatt caccaccctg aattgactct 4620
cttccgggcg ctatcatgcc ataccgcgaa aggttttgcg ccattcgatg gtgtccggga 4680
tctcgacgct ctcccttatg cgactcctgc attaggaagc agcccagtag taggttgagg 4740
ccgttgagca ccgccgccgc aaggaatggt gcatgcaagg agatggcgcc caacagtccc 4800
ccggccacgg ggcctgccac catacccacg ccgaaacaag cgctcatgag cccgaagtgg 4860
cgagcccgat cttccccatc ggtgatgtcg gcgatatagg cgccagcaac cgcacctgtg 4920
gcgccggtga tgccggccac gatgcgtccg gcgtagagga tcgagatctc gatcccgcga 4980
aattaatacg actcactata ggggaattgt gagcggataa caattcccct ctagaaataa 5040
ttttgtttaa ctttaagaag gagatatacc atgggcatgg cgaccccggt gaaaaaatgg 5100
ctgctgcgcg tggcgccgtg gtttctgccg gtgggcattg tggcggtgtg gcagctggcg 5160
agcagcgtgg gctggctgag cacccgcatt ctgccgagcc cggaaggcgt ggtgaccgcg 5220
ttttggaccc tgagcgcgag cggcgaactg tggcagcatc tggcgattag cagctggcgc 5280
gcgctgattg gctttagcat tggcggcagc ctgggcctga ttctgggcct gattagcggc 5340
ctgagccgct ggggcgaacg cctgctggat accagcattc agatgctgcg caacgtgccg 5400
catctggcgc tgattccgct ggtgattctg tggtttggca ttgatgaaag cgcgaaaatt 5460
tttctggtgg cgctgggcac cctgtttccg atttatatta acacctggca tggcattcgc 5520
aacattgatc gcggcctggt ggaaatggcg cgcagctatg gcctgagcgg cattccgctg 5580
tttattcatg tgattctgcc gggcgcgctg ccgagcatta tggtgggcgt gcgctttgcg 5640
ctgggcctga tgtggctgac cctgattgtg gcggaaacca ttagcgcgaa cagcggcatt 5700
ggctatctgg cgatgaacgc gcgcgaattt ctgcagaccg atgtggtggt ggtggcgatt 5760
attctgtatg cgctgctggg caaactggcg gatgtgagcg cgcagctgct ggaacgcctg 5820
tggctgcgct ggaacccggc gtatcatctg aaagaagcga ccgtgggatc cggactgcag 5880
gagaacctgt acttccaatc ccaccatatg tctaaaggtg aagaactgtt caccggtgtt 5940
gttccgatcc tggttgaact ggacggtgac gttaacggtc acaaattctc tgttcgtggt 6000
gaaggtgaag gtgacgctac caacggtaaa ctgaccctga aattcatctg caccaccggt 6060
aaactgccgg ttccgtggcc gaccctggtt accaccctga cctacggtgt tcagtgcttc 6120
tctcgttacc cggaccacat gaaacgtcac gacttcttca aatctgctat gccggaaggt 6180
tacgttcagg aacgtaccat ctctttcaaa gacgacggta cctacaaaac ccgtgctgaa 6240
gttaaattcg aaggtgacac cctggttaac cgtatcgaac tgaaaggtat cgacttcaaa 6300
gaagacggta acatcctggg tcacaaactg gaatacaact tcaactctca caacgtttac 6360
atcaccgctg acaaacagaa aaacggtatc aaagctaact tcaaaatccg tcacaacgtt 6420
gaagacggtt ctgttcagct ggctgaccac taccagcaga acaccccgat cggtgacggt 6480
ccggttctgc tgccggacaa ccactacctg tctacccagt ctgttctgtc taaagacccg 6540
aacgaaaaac gtgaccacat ggttctgctg gaattcgtta ccgctgctgg tatcacccac 6600
ggtatggacg aactgtacaa actcgagcac caccaccacc accactgaga tccggctgct 6660
aacaaagccc gaaaggaagc tgagttggct gctgccaccg ctgagcaata actagcataa 6720
ccccttgggg cctctaaacg ggtcttgagg ggttttttgc tgaaaggagg aactatatcc 6780
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010049434.6A CN113136395A (en) | 2020-01-16 | 2020-01-16 | Expression vector of membrane protein YcbM and expression and purification method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010049434.6A CN113136395A (en) | 2020-01-16 | 2020-01-16 | Expression vector of membrane protein YcbM and expression and purification method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113136395A true CN113136395A (en) | 2021-07-20 |
Family
ID=76808498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010049434.6A Pending CN113136395A (en) | 2020-01-16 | 2020-01-16 | Expression vector of membrane protein YcbM and expression and purification method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113136395A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008105276A1 (en) * | 2007-02-20 | 2008-09-04 | Ajinomoto Co., Inc. | A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY WITH ATTENUATED EXPRESSION OF THE ycbPONME OPERON (ssuEADCB OPERON) |
-
2020
- 2020-01-16 CN CN202010049434.6A patent/CN113136395A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008105276A1 (en) * | 2007-02-20 | 2008-09-04 | Ajinomoto Co., Inc. | A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY WITH ATTENUATED EXPRESSION OF THE ycbPONME OPERON (ssuEADCB OPERON) |
Non-Patent Citations (4)
Title |
---|
DAVID DREW ET AL.: "GFP-based optimization scheme for the overexpression and purification of eukaryotic membrane proteins in Saccharomyces cerevisiae", 《NATURE》 * |
DAVID DREW ET AL.: "Rapid topology mapping of Escherichia coli inner-membrane proteins by prediction and PhoA /GFP fusion analysis", 《PNAS》 * |
JEAN-DENIS PEDELACQ ET AL.: "Engineering and characterization of a superfolder green fluorescent protein", 《NATURE BIOTECHNOLOGY》 * |
PLOEG ET AL.: "The Escherichia coli ssuEADCB Gene Cluster Is Required for the Utilization of Sulfur from Aliphatic Sulfonates and Is Regulated by the Transcriptional Activator Cbl", 《THE JOURNAL OF BIOLOGICAL CHEMISTRY》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111454978B (en) | Surface display engineering bacterium for specifically adsorbing heavy metal lead and construction method and application thereof | |
CN111304232B (en) | Method for purifying protein based on membrane surface fusion expression strategy and its application | |
CN113621638A (en) | Method for constructing Escherichia coli producing L-serine | |
CN111850007B (en) | A cellulosome docking protein combinatorial mutant 36864 suitable for low calcium ion concentration and its application | |
KR102808158B1 (en) | Bacterial expression vectors for enhanced protein secretion | |
CN114774452B (en) | Construction method and application of engineering escherichia coli for adsorbing mercury ions in solution | |
CN114854822A (en) | High-throughput screening method for phenylethanolamine-N-methyltransferase | |
CN114875004B (en) | High-stereoselectivity R-transketolase mutant and encoding gene and application thereof | |
CN111848758B (en) | Cellulosome docking protein mutant suitable for low calcium ion concentration and application | |
CN113583928A (en) | Salmonella typhimurium green fluorescent strain and construction method thereof | |
CN114150002A (en) | A kind of light-controlled gene switch and its application | |
CN111848757B (en) | Cellulosome docking protein combined mutant 36862 suitable for low calcium ion concentration and application | |
CN113322243B (en) | Protein UGT236 and its encoding gene and application | |
CN113151214B (en) | Protein PnlipA with lipase activity and gene and application thereof | |
CN111850005B (en) | Cellulosome docking protein combined mutant 36863 suitable for low calcium ion concentration and application | |
CN113122561B (en) | Expression vector of membrane protein SohB and expression and purification method thereof | |
CN115216485A (en) | Amikacin-resistant recombinant plasmid pET28a(+)-rmtB and its application | |
CN113122558B (en) | Expression vector of membrane protein AmpG and expression and purification method thereof | |
CN109593698B (en) | A kind of water-adsorbing heavy metal Escherichia coli transformant and its application | |
CN113136395A (en) | Expression vector of membrane protein YcbM and expression and purification method thereof | |
CN113337491A (en) | Structural domain for improving high-temperature resistance stability of keratinase and application thereof | |
CN112592877A (en) | Recombinant escherichia coli for over-expressing lsrC gene and construction method and application thereof | |
CN113122562A (en) | Expression vector of membrane protein YddG and expression and purification method thereof | |
CN113122559A (en) | Expression vector of membrane protein SecF and expression and purification method thereof | |
CN113122560A (en) | Expression vector of membrane protein FieF and expression and purification method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210720 |